Latest Insider Transactions at Cerus Corp (CERS)
This section provides a real-time view of insider transactions for Cerus Corp (CERS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CERUS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CERUS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 16
2021
|
William Mariner Greenman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
233,859
-14.15%
|
$1,403,154
$6.35 P/Share
|
|
Apr 16
2021
|
William Mariner Greenman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
550,000
+24.97%
|
$1,100,000
$2.7 P/Share
|
|
Mar 15
2021
|
Carol Moore SVP Reg. & Quality |
SELL
Open market or private sale
|
Direct |
29,331
-5.65%
|
$175,986
$6.38 P/Share
|
|
Mar 15
2021
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
29,331
-10.01%
|
$175,986
$6.38 P/Share
|
|
Mar 15
2021
|
Richard J Benjamin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
49,331
-13.6%
|
$295,986
$6.37 P/Share
|
|
Mar 15
2021
|
Laurence M Corash Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
23,775
-0.61%
|
$142,650
$6.38 P/Share
|
|
Mar 15
2021
|
William Mariner Greenman President and CEO |
SELL
Open market or private sale
|
Direct |
156,407
-4.69%
|
$938,442
$6.38 P/Share
|
|
Mar 15
2021
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,331
-6.65%
|
$175,986
$6.38 P/Share
|
|
Mar 15
2021
|
Vivek K Jayaraman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
37,149
-6.32%
|
$222,894
$6.38 P/Share
|
|
Mar 12
2021
|
Carol Moore SVP Reg. & Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
83,603
+13.62%
|
-
|
|
Mar 12
2021
|
Chrystal Menard Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,603
+21.77%
|
-
|
|
Mar 12
2021
|
Richard J Benjamin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,603
+23.73%
|
-
|
|
Mar 12
2021
|
Laurence M Corash Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,603
+1.4%
|
-
|
|
Mar 12
2021
|
William Mariner Greenman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
327,696
+8.94%
|
-
|
|
Mar 12
2021
|
Kevin Dennis Green Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,603
+15.65%
|
-
|
|
Mar 12
2021
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
103,733
+14.83%
|
-
|
|
Mar 04
2021
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,127
+28.82%
|
-
|
|
Feb 16
2021
|
Daniel N Swisher Jr Director |
SELL
Open market or private sale
|
Direct |
10,000
-14.31%
|
$70,000
$7.78 P/Share
|
|
Feb 16
2021
|
Daniel N Swisher Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.52%
|
$20,000
$2.9 P/Share
|
|
Feb 08
2021
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,125
-7.72%
|
$65,000
$8.0 P/Share
|
|
Feb 08
2021
|
Chrystal Menard Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,125
+7.16%
|
$32,500
$4.33 P/Share
|
|
Dec 22
2020
|
Timothy B Anderson Director |
SELL
Open market or private sale
|
Direct |
39,336
-8.47%
|
$314,688
$8.38 P/Share
|
|
Dec 22
2020
|
Timothy B Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+11.11%
|
$150,000
$5.4 P/Share
|
|
Dec 22
2020
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
211,327
-58.8%
|
$1,690,616
$8.0 P/Share
|
|
Dec 22
2020
|
Chrystal Menard Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
211,327
+36.99%
|
$845,308
$4.37 P/Share
|
|
Dec 22
2020
|
Vivek K Jayaraman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
56,105
-15.15%
|
$448,840
$8.0 P/Share
|
|
Dec 22
2020
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,105
+12.0%
|
$224,420
$4.33 P/Share
|
|
Dec 14
2020
|
Gail Schulze Director |
SELL
Open market or private sale
|
Direct |
62,393
-62.02%
|
$436,751
$7.38 P/Share
|
|
Dec 14
2020
|
Gail Schulze Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.38%
|
$30,000
$2.48 P/Share
|
|
Dec 11
2020
|
Vivek K Jayaraman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
43,895
-13.09%
|
$351,160
$8.0 P/Share
|
|
Dec 11
2020
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,895
+9.55%
|
$75,580
$4.33 P/Share
|
|
Dec 11
2020
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
41,363
-16.36%
|
$330,904
$8.0 P/Share
|
|
Dec 11
2020
|
Chrystal Menard Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,363
+13.49%
|
$165,452
$4.39 P/Share
|
|
Nov 17
2020
|
Daniel N Swisher Jr Director |
SELL
Open market or private sale
|
Direct |
10,000
-14.31%
|
$60,000
$6.25 P/Share
|
|
Nov 17
2020
|
Daniel N Swisher Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.52%
|
$20,000
$2.9 P/Share
|
|
Nov 10
2020
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
32,928
-12.63%
|
$164,640
$5.5 P/Share
|
|
Oct 05
2020
|
Eric Bjerkholt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,281
+13.03%
|
-
|